Effect of naive and radiolabeled rhTRAIL on the cervical cancer xenografts in mice
- PMID: 24483193
- DOI: 10.4155/tde.13.137
Effect of naive and radiolabeled rhTRAIL on the cervical cancer xenografts in mice
Abstract
Background: There is a need for novel treatments of advanced cervical cancer. We investigated the utility of recombinant human TNF-related apoptosis-inducing ligand (rhTRAIL), a molecule capable of inducing apoptosis in cancer cells, for the therapy of CasKi cervical cancer xenografts in nude mice.
Results: CasKi cells proved to be sensitive in vitro to rhTRAIL with an IC50 of 120 ng/ml. (125)I-tagged rhTRAIL specifically accumulated in CasKi tumors in mice with the highest uptake of 9.4% ID/g at 2 h post-injection. Both naive and 200 µCi (188)Re-tagged rhTRAIL administered in the amount of 0.35 mg/kg body weight significantly retarded CasKi tumor growth to the same extent in mice without the side effects of cisplatin chemotherapeutic control.
Conclusion: rhTRAIL is a promising novel agent for treatment of advanced cervical cancer.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical